Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA
ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interac...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a3287 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8d6c465583e4410c8afdd48c4a9a3287 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8d6c465583e4410c8afdd48c4a9a32872021-11-15T15:52:19ZSynergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA10.1128/mBio.02101-172150-7511https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a32872018-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02101-17https://doaj.org/toc/2150-7511ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interacting DG167 molecules occupying nonidentical sites in the substrate-binding channel of KasA. The binding affinities of KasA to DG167 and its analog, 5g, which binds only once in the substrate-binding channel, were determined, along with the KasA-5g X-ray crystal structure. DG167 strongly augmented the in vitro activity of isoniazid (INH), leading to synergistic lethality, and also synergized in an acute mouse model of M. tuberculosis infection. Synergistic lethality correlated with a unique transcriptional signature, including upregulation of oxidoreductases and downregulation of molecular chaperones. The lead structure-activity relationships (SAR), pharmacokinetic profile, and detailed interactions with the KasA protein that we describe may be applied to evolve a next-generation therapeutic strategy for tuberculosis (TB). IMPORTANCE Cell wall biosynthesis inhibitors have proven highly effective for treating tuberculosis (TB). We discovered and validated members of the indazole sulfonamide class of small molecules as inhibitors of Mycobacterium tuberculosis KasA—a key component for biosynthesis of the mycolic acid layer of the bacterium’s cell wall and the same pathway as that inhibited by the first-line antitubercular drug isoniazid (INH). One lead compound, DG167, demonstrated synergistic lethality in combination with INH and a transcriptional pattern consistent with bactericidality and loss of persisters. Our results also detail a novel dual-binding mechanism for this compound as well as substantial structure-activity relationships (SAR) that may help in lead optimization activities. Together, these results suggest that KasA inhibition, specifically, that shown by the DG167 series, may be developed into a potent therapy that can synergize with existing antituberculars.Pradeep KumarGlenn C. CapodagliDivya AwasthiRiju ShresthaKarishma MaharajaParidhi SukhejaShao-Gang LiDaigo InoyamaMatthew ZimmermanHsin Pin Ho LiangJansy SarathyMarizel MinaGeorge RasicRiccardo RussoAlexander L. PerrymanTodd RichmannAditi GuptaEric SingletonSheetal VermaSeema HusainPatricia SoteropoulosZhe WangRoxanne MorrisGene PorterGautam AgnihotriPadmini SalgameSean EkinsKyu Y. RheeNancy ConnellVéronique DartoisMatthew B. NeiditchJoel S. FreundlichDavid AllandAmerican Society for MicrobiologyarticleantitubercularDG167KasAMycobacterium tuberculosismycolic acid biosynthesisdrug developmentMicrobiologyQR1-502ENmBio, Vol 9, Iss 6 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
antitubercular DG167 KasA Mycobacterium tuberculosis mycolic acid biosynthesis drug development Microbiology QR1-502 |
spellingShingle |
antitubercular DG167 KasA Mycobacterium tuberculosis mycolic acid biosynthesis drug development Microbiology QR1-502 Pradeep Kumar Glenn C. Capodagli Divya Awasthi Riju Shrestha Karishma Maharaja Paridhi Sukheja Shao-Gang Li Daigo Inoyama Matthew Zimmerman Hsin Pin Ho Liang Jansy Sarathy Marizel Mina George Rasic Riccardo Russo Alexander L. Perryman Todd Richmann Aditi Gupta Eric Singleton Sheetal Verma Seema Husain Patricia Soteropoulos Zhe Wang Roxanne Morris Gene Porter Gautam Agnihotri Padmini Salgame Sean Ekins Kyu Y. Rhee Nancy Connell Véronique Dartois Matthew B. Neiditch Joel S. Freundlich David Alland Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
description |
ABSTRACT We report GSK3011724A (DG167) as a binary inhibitor of β-ketoacyl-ACP synthase (KasA) in Mycobacterium tuberculosis. Genetic and biochemical studies established KasA as the primary target. The X-ray crystal structure of the KasA-DG167 complex refined to 2.0-Å resolution revealed two interacting DG167 molecules occupying nonidentical sites in the substrate-binding channel of KasA. The binding affinities of KasA to DG167 and its analog, 5g, which binds only once in the substrate-binding channel, were determined, along with the KasA-5g X-ray crystal structure. DG167 strongly augmented the in vitro activity of isoniazid (INH), leading to synergistic lethality, and also synergized in an acute mouse model of M. tuberculosis infection. Synergistic lethality correlated with a unique transcriptional signature, including upregulation of oxidoreductases and downregulation of molecular chaperones. The lead structure-activity relationships (SAR), pharmacokinetic profile, and detailed interactions with the KasA protein that we describe may be applied to evolve a next-generation therapeutic strategy for tuberculosis (TB). IMPORTANCE Cell wall biosynthesis inhibitors have proven highly effective for treating tuberculosis (TB). We discovered and validated members of the indazole sulfonamide class of small molecules as inhibitors of Mycobacterium tuberculosis KasA—a key component for biosynthesis of the mycolic acid layer of the bacterium’s cell wall and the same pathway as that inhibited by the first-line antitubercular drug isoniazid (INH). One lead compound, DG167, demonstrated synergistic lethality in combination with INH and a transcriptional pattern consistent with bactericidality and loss of persisters. Our results also detail a novel dual-binding mechanism for this compound as well as substantial structure-activity relationships (SAR) that may help in lead optimization activities. Together, these results suggest that KasA inhibition, specifically, that shown by the DG167 series, may be developed into a potent therapy that can synergize with existing antituberculars. |
format |
article |
author |
Pradeep Kumar Glenn C. Capodagli Divya Awasthi Riju Shrestha Karishma Maharaja Paridhi Sukheja Shao-Gang Li Daigo Inoyama Matthew Zimmerman Hsin Pin Ho Liang Jansy Sarathy Marizel Mina George Rasic Riccardo Russo Alexander L. Perryman Todd Richmann Aditi Gupta Eric Singleton Sheetal Verma Seema Husain Patricia Soteropoulos Zhe Wang Roxanne Morris Gene Porter Gautam Agnihotri Padmini Salgame Sean Ekins Kyu Y. Rhee Nancy Connell Véronique Dartois Matthew B. Neiditch Joel S. Freundlich David Alland |
author_facet |
Pradeep Kumar Glenn C. Capodagli Divya Awasthi Riju Shrestha Karishma Maharaja Paridhi Sukheja Shao-Gang Li Daigo Inoyama Matthew Zimmerman Hsin Pin Ho Liang Jansy Sarathy Marizel Mina George Rasic Riccardo Russo Alexander L. Perryman Todd Richmann Aditi Gupta Eric Singleton Sheetal Verma Seema Husain Patricia Soteropoulos Zhe Wang Roxanne Morris Gene Porter Gautam Agnihotri Padmini Salgame Sean Ekins Kyu Y. Rhee Nancy Connell Véronique Dartois Matthew B. Neiditch Joel S. Freundlich David Alland |
author_sort |
Pradeep Kumar |
title |
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
title_short |
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
title_full |
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
title_fullStr |
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
title_full_unstemmed |
Synergistic Lethality of a Binary Inhibitor of <named-content content-type="genus-species">Mycobacterium tuberculosis</named-content> KasA |
title_sort |
synergistic lethality of a binary inhibitor of <named-content content-type="genus-species">mycobacterium tuberculosis</named-content> kasa |
publisher |
American Society for Microbiology |
publishDate |
2018 |
url |
https://doaj.org/article/8d6c465583e4410c8afdd48c4a9a3287 |
work_keys_str_mv |
AT pradeepkumar synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT glennccapodagli synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT divyaawasthi synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT rijushrestha synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT karishmamaharaja synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT paridhisukheja synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT shaogangli synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT daigoinoyama synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT matthewzimmerman synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT hsinpinholiang synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT jansysarathy synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT marizelmina synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT georgerasic synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT riccardorusso synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT alexanderlperryman synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT toddrichmann synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT aditigupta synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT ericsingleton synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT sheetalverma synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT seemahusain synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT patriciasoteropoulos synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT zhewang synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT roxannemorris synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT geneporter synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT gautamagnihotri synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT padminisalgame synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT seanekins synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT kyuyrhee synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT nancyconnell synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT veroniquedartois synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT matthewbneiditch synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT joelsfreundlich synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa AT davidalland synergisticlethalityofabinaryinhibitorofnamedcontentcontenttypegenusspeciesmycobacteriumtuberculosisnamedcontentkasa |
_version_ |
1718427288576458752 |